RXi Pharmaceuticals, Mirna Therapeutics Form Research Collaboration

RXi Pharmaceuticals Corp., a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, said that it has entered into a research collaboration with Mirna Therapeutics to determine the utility of combining RXi’s proprietary rxRNA technology with Mirna’s microRNA mimics as potential therapeutics in oncology.
TradingMarkets